1. Home
  2. CADL vs IHRT Comparison

CADL vs IHRT Comparison

Compare CADL & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADL
  • IHRT
  • Stock Information
  • Founded
  • CADL 1999
  • IHRT 1974
  • Country
  • CADL United States
  • IHRT United States
  • Employees
  • CADL N/A
  • IHRT N/A
  • Industry
  • CADL Biotechnology: Pharmaceutical Preparations
  • IHRT Broadcasting
  • Sector
  • CADL Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • CADL Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • CADL 234.8M
  • IHRT N/A
  • IPO Year
  • CADL 2021
  • IHRT 2019
  • Fundamental
  • Price
  • CADL $4.76
  • IHRT $1.21
  • Analyst Decision
  • CADL Strong Buy
  • IHRT Buy
  • Analyst Count
  • CADL 4
  • IHRT 3
  • Target Price
  • CADL $21.00
  • IHRT $2.83
  • AVG Volume (30 Days)
  • CADL 864.6K
  • IHRT 598.4K
  • Earning Date
  • CADL 05-13-2025
  • IHRT 05-12-2025
  • Dividend Yield
  • CADL N/A
  • IHRT N/A
  • EPS Growth
  • CADL N/A
  • IHRT N/A
  • EPS
  • CADL N/A
  • IHRT N/A
  • Revenue
  • CADL N/A
  • IHRT $3,854,532,000.00
  • Revenue This Year
  • CADL N/A
  • IHRT $0.97
  • Revenue Next Year
  • CADL N/A
  • IHRT $5.09
  • P/E Ratio
  • CADL N/A
  • IHRT N/A
  • Revenue Growth
  • CADL N/A
  • IHRT 2.76
  • 52 Week Low
  • CADL $3.79
  • IHRT $0.81
  • 52 Week High
  • CADL $14.60
  • IHRT $2.84
  • Technical
  • Relative Strength Index (RSI)
  • CADL 41.42
  • IHRT 51.94
  • Support Level
  • CADL $4.80
  • IHRT $1.02
  • Resistance Level
  • CADL $5.34
  • IHRT $1.09
  • Average True Range (ATR)
  • CADL 0.33
  • IHRT 0.08
  • MACD
  • CADL 0.10
  • IHRT 0.04
  • Stochastic Oscillator
  • CADL 42.09
  • IHRT 86.67

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: